tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Zhong Ji Longevity Science Reports Revenue Growth but Faces Profit Decline in H1 2025

Story Highlights
Zhong Ji Longevity Science Reports Revenue Growth but Faces Profit Decline in H1 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Zhong Ji Longevity Science Group Limited ( (HK:0767) ) has shared an announcement.

Zhong Ji Longevity Science Group Limited announced its interim results for the first half of 2025, revealing a 13.1% increase in revenue to HK$48.0 million compared to the previous year. Despite the revenue growth, the company faced a significant decrease in gross profit by 51.8% and recorded a loss before tax of approximately HK$11.5 million. The company’s net assets, however, increased by 7.9% to HK$431.5 million. No interim dividend was recommended for the period.

More about Zhong Ji Longevity Science Group Limited

Zhong Ji Longevity Science Group Limited is a company incorporated in Bermuda, operating in the longevity science sector. The company focuses on providing products and services aimed at enhancing longevity and health, with a market presence that spans various regions.

Average Trading Volume: 1,519,525

Technical Sentiment Signal: Buy

Current Market Cap: HK$375.6M

For an in-depth examination of 0767 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1